PubMed Health⌕ Search

Biomedical subjects

R Fitz

Publications and source records attributed to R Fitz.

25 records · Page 2Linked to original sources

[Hormonal status in patients with Mayer-Rokitansky-Küster syndrome].

A characteristic and comparatively frequent malformation of the female genital tract is the congenital absence of the vagina and a rudimentary uterus, known as Mayer-Rokitansky-Küster syndrome. Since we employ the modified surgical technique according to Vecchetti we have a relatively large incidence of patients with this syndrome. Thus, a total of 15 patients were hospitalised for a thorough endocrinological examination including a GnRH test with 2 bolus injections of GnRH, TRH-test, the determination of testosterone, DHEAS, androstendione and gonadotropin as well as prolactin fluctuation over a 4-hour period. The values of 4 patients without any endocrinological disorder served as control group. 2 of the 15 patients showed an increase in androgenic hormones; 8 patients a slight hyperprolactinaemia disclosed by the TRH test. The gonadotropin fluctuation in all patients was restricted and the stimulation of the pituitary gland with GnRH bolus injections was diminished. The naloxone test led to a significant increase in peripheral gonadotropins. It remains to be determined whether this endocrinological disorder is the cause or the outcome of the rudimentary inner genitals.

Adolescent↗

A RUM COCKTAIL.

Explore the source record for details and available documents.

Journal Article↗

Clinical study with recombinant interferon gamma versus interferon alpha-2c in patients with condylomata acuminata.

A multi-centre, randomized, open-label trial was conducted to evaluate the safety and efficacy of recombinant interferon (rIFN) alpha-2c versus rIFN gamma in patients with recurrent or persistent condylomata acuminata (CA). Thirty-three such patients were treated either with 6 micrograms rIFN alpha-2c or with 0.1 mg rIFN gamma (both equivalent to 2 x 10E6 IU), single dose, subcutaneously 3 times a week for 6 weeks. In case of no complete clearance at week 10, a second course of treatment with the other type of rIFN was given. There was no significant difference in the complete clearance proportions at week 10 between the two treatment groups (3/16 vs 6/17). No relapses occurred in these patients during the 16 weeks' follow-up. Further clearances during the follow-up resulted in a total complete clearance proportion of 14/33 at the end of study. The treatment was well tolerated. Repeated interferon therapy has its place in treating persistent or recurrent condylomas.

Adolescent↗

[Atrial natriuretic peptide, antidiuretic hormone and aldosterone during delivery and the puerperium].

Plasma concentrations of ANP, Aldosteron and ADH were determined immediately ante- and post-partum and on the second day of puerperium in 36 healthy women, 12 primiparous and 24 multiparous. These parameters were also measured by RIA in umbilical cord plasma obtained at the time of delivery. The values were compared with an age-matched group of non pregnant women. The mean ANP-values before and after birth showed no significant difference but they were higher than in the non pregnant controls, and in umbilical cord plasma. The mean Aldosteron values during pregnancy and puerperium were significantly elevated against the non pregnant women, but they showed a marked decrease on the second day of puerperium. The mean Aldosteron levels in umbilical cord plasma were higher than all pregnant values. The mean ADH-levels before and after birth were also elevated against the non pregnant group, but on the second day of puerperium a significant decrease was established. The mean values of umbilical cord plasma were significantly elevated against all other maternal and non pregnant values.

Adolescent↗